☰

Edwin Chang - Publications

Affiliations: 
Radiology Stanford University School of Medicine, Palo Alto, CA, United States 
Tree Info Similar researchers PubMed Report error

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Nguyen H, Schubert KE, Pohling C, Chang E, Yamamoto V, Zeng Y, Nie Y, Van Buskirk SL, Schulte RW, Patel CB. Impact of glioma peritumoral edema, tumor size, and tumor location on alternating electric fields (AEF) therapy in realistic 3D rat glioma models: a computational study. Physics in Medicine and Biology. PMID 38417178 DOI: 10.1088/1361-6560/ad2e6c  0.499
2023 Nguyen H, Schubert KE, Chang E, Nie Y, Pohling C, Van Buskirk SL, Yamamoto V, Zeng Y, Schulte RW, Patel CB. Electric field distributions in realistic 3D rat head models during alternating electric field (AEF) therapy: a computational study. Physics in Medicine and Biology. PMID 37703902 DOI: 10.1088/1361-6560/acf98d  0.484
2022 Pohling C, Nguyen H, Chang E, Schubert KE, Nie Y, Bashkirov V, Yamamoto V, Zeng Y, Stupp R, Schulte RW, Patel CB. Current status of the preclinical evaluation of alternating electric fields as a form of cancer therapy. Bioelectrochemistry (Amsterdam, Netherlands). 149: 108287. PMID 36306728 DOI: 10.1016/j.bioelechem.2022.108287  0.502
2022 Arami H, Kananian S, Khalifehzadeh L, Patel CB, Chang E, Tanabe Y, Zeng Y, Madsen SJ, Mandella MJ, Natarajan A, Peterson EE, Sinclair R, Poon ASY, Gambhir SS. Remotely controlled near-infrared-triggered photothermal treatment of brain tumours in freely behaving mice using gold nanostars. Nature Nanotechnology. PMID 35995855 DOI: 10.1038/s41565-022-01189-y  0.398
2021 Wu W, Klockow JL, Zhang M, Lafortune F, Chang E, Jin L, Wu Y, Daldrup-Link HE. Glioblastoma Multiforme (GBM): An overview of current therapies and mechanisms of resistance. Pharmacological Research. 105780. PMID 34302977 DOI: 10.1016/j.phrs.2021.105780  0.306
2021 Aguilar AA, Ho MC, Chang E, Carlson KW, Natarajan A, Marciano T, Bomzon Z, Patel CB. Permeabilizing Cell Membranes with Electric Fields. Cancers. 13. PMID 34068775 DOI: 10.3390/cancers13092283  0.501
2021 Patel C, Beinat C, Xie Y, Chang E, Gambhir S. BIMG-16. TRACKING TTFIELDS-INDUCED ALTERATIONS IN GLIOBLASTOMA METABOLISM WITH [18F]DASA-23, A NON-INVASIVE PROBE OF PYRUVATE KINASE M2 (PKM2) Neuro-Oncology Advances. 3: i4-i4. DOI: 10.1093/noajnl/vdab024.015  0.466
2020 Patel CB, Beinat C, Xie Y, Chang E, Gambhir SS. Tumor treating fields (TTFields) impairs aberrant glycolysis in glioblastoma as evaluated by [F]DASA-23, a non-invasive probe of pyruvate kinase M2 (PKM2) expression. Neoplasia (New York, N.Y.). 23: 58-67. PMID 33221711 DOI: 10.1016/j.neo.2020.11.003  0.476
2020 Chang E, Patel C, Young C, Flores T, Zeng Y, Joubert L, Arami H, Natarajan A, Sinclair R, Gambhir S. CSIG-14. COMBINING THE GLIOBLASTOMA CELL MEMBRANE-PERMEABILIZING EFFECT OF TUMOR TREATING FIELDS (TTFIELDS) WITH WITHAFERIN A (AND OTHER) CHEMOTHERAPY Neuro-Oncology. 22: ii30-ii30. DOI: 10.1093/neuonc/noaa215.126  0.357
2019 Patel CB, Beinat C, Xie Y, Chang E, Gambhir SS. Abstract 5271: Molecular imaging of pyruvate kinase M2 (PKM2) with [18F]DASA-23 detects temozolomide- and tumor treating fields (TTFields)-induced changes in glycolysis in glioblastoma Cancer Research. 79: 5271-5271. DOI: 10.1158/1538-7445.Am2019-5271  0.406
2019 Chang E, Patel C, Pohling C, Young C, Song J, Flores TA, Zeng Y, Joubert LM, Arami H, Natarajan A, Sinclair R, Gambhir SS. Abstract 250: Tumor treating fields increases membrane permeability in glioblastoma cells Cancer Research. 79: 250-250. DOI: 10.1158/1538-7445.Am2019-250  0.428
2019 Chang E, Patel C, Beinat C, Young C, Flores T, Zeng Y, Joubert L, Arami H, Natarajan A, Sinclair R, Gambhir S. EXTH-53. TUMOR TREATING FIELDS LEADS TO CHANGES IN MEMBRANE PERMEABILITY AND INCREASED PENETRATION BY ANTI-GLIOMA DRUGS Neuro-Oncology. 21: vi93-vi93. DOI: 10.1093/Neuonc/Noz175.384  0.354
2018 Chang E, Patel CB, Pohling C, Young C, Song J, Flores TA, Zeng Y, Joubert LM, Arami H, Natarajan A, Sinclair R, Gambhir SS. Tumor treating fields increases membrane permeability in glioblastoma cells. Cell Death Discovery. 4: 113. PMID 30534421 DOI: 10.1038/S41420-018-0130-X  0.51
2018 Chang E, Patel C, Pohling C, Beygui N, Ha DH, Gambhir SS. Abstract 5828: Withaferin A and tumor treating fields synergistically inhibit glioma proliferation Cancer Research. 78: 5828-5828. DOI: 10.1158/1538-7445.Am2018-5828  0.357
2018 Patel C, Beinat C, Xie Y, Haywood T, Murty S, Chang E, Gambhir S. CBMT-03. A NOVEL METABOLIC PET TRACER STRATEGY TO DETERMINE EARLY EFFECTS OF TUMOR TREATING FIELDS (TTFIELDS) Neuro-Oncology. 20: vi32-vi33. DOI: 10.1093/Neuonc/Noy148.122  0.305
2017 Chang E, Pohling C, Beygui N, Patel CB, Rosenberg J, Ha DH, Gambhir SS. Synergistic inhibition of glioma cell proliferation by Withaferin A and tumor treating fields. Journal of Neuro-Oncology. PMID 28681243 DOI: 10.1007/S11060-017-2534-5  0.495
2017 Chang E, Pohling C, Beygui N, Patel CB, Rosenberg J, Ha DH, Gambhir SS. DDIS-15. SYNERGISTIC INHIBITION OF GLIOMA CELL PROLIFERATION BY WITHAFERIN A AND TUMOR TREATING FIELDS Neuro-Oncology. 19: vi61-vi62. DOI: 10.1093/neuonc/nox168.250  0.337
2012 Xu Y, Chang E, Liu H, Jiang H, Gambhir SS, Cheng Z. Proof-of-concept study of monitoring cancer drug therapy with cerenkov luminescence imaging. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 312-7. PMID 22241909 DOI: 10.2967/Jnumed.111.094623  0.312
2011 Chang E, Liu S(, Berhoerster K, Ellinghaus P, Liu S(, Gekeler V, Cheng Z, Berndorff D, Gambhir SS. Abstract LB-147: 18F-FAZA-PET as a pharmacodynamic biomarker of anti-tumor activity for the novel HIF-1α pathway inhibitor BAY 87–2243 in preclinical tumor models Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-147  0.313
Show low-probability matches.